Deficient prepulse inhibition induced by selective breeding of rats can be restored by the dopamine D2 antagonist haloperidol

Behavioural Brain Research

Volumn 177, Issue 2, 2007, Pages 364-367

  Hadamitzky, Martin ^a   Harich, Silke ^a   Koch, Michael ^a   Schwabe, Kerstin ^b  

^a UNIVERSITY OF BREMEN   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Animal model; Clozapine; Endophenotype; Haloperidol; Startle reflex

Indexed keywords

CLOZAPINE; DOPAMINE 2 RECEPTOR BLOCKING AGENT; HALOPERIDOL; NEUROLEPTIC AGENT;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DRUG EFFICACY; FEMALE; INFORMATION PROCESSING; MALE; MENTAL DISEASE; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; SCORING SYSTEM; SEXUAL BEHAVIOR; STARTLE REFLEX;

ACOUSTIC STIMULATION; ANIMALS; BEHAVIOR, ANIMAL; BREEDING; CLOZAPINE; DOPAMINE ANTAGONISTS; FEMALE; GAIT DISORDERS, NEUROLOGIC; HALOPERIDOL; INHIBITION (PSYCHOLOGY); MALE; RATS; RATS, WISTAR; SEROTONIN ANTAGONISTS; SEX FACTORS; STARTLE REACTION;

EID: 33846431999     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2006.11.037     Document Type: Article

References (21)

1. Bakshi V.P., Swerdlow N.R., and Geyer M.A. Clozapine antagonizes phencyclidine induced deficits in sensorimotor gating of the startle response. J Pharmacol Exp Ther 271 (1994) 787-794 2
2. Braff D.L., Geyer M.A., and Swerdlow N.R. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology 156 (2001) 234-258
3. Ellenbroek B.A., Sluyter F., and Cools A.R. The role of genetic and early environmental factors in determining apomorphine susceptibility. Psychopharmacology 148 (2000) 124-131
4. Geyer M.A., and Markou A. Animal models of psychiatric disorders. In: Bloom F.E., and Kupfer D.J. (Eds). Psychopharmacology: the fourth generation of progress (1995), Raven Press, New York 787-798
5. Geyer M.A., Krebs-Thomson K., Braff D.L., and Swerdlow N.R. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology 156 (2001) 117-154
6. Hashimoto T., Volk D.W., Eggan S.M., Mirnics K., Pierri J.N., Sun Z., et al. Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J Neurosci 23 (2003) 6315-6326
7. Holmes A., and Crawley J.N. Promises and limitations of transgenic and knockout mice in modeling psychiatric symptoms. In: Myslobodsky M.S., and Weiner I. (Eds). Contemporary issues in modelling psychopathology (2000), Kluwer Akademic Publishers, Boston/Dordrecht/London 55-78
8. Kilts C.D. The changing roles and targets for animal models of schizophrenia. Biol Psychiat 50 (2001) 845-855
9. Koch M. The neurobiology of startle. Prog Neurobiol 59 (1999) 107-128
10. Koch M. Animal models of schizophrenia. In: Koch M. (Ed). Animal models of Neuropsychiatric diseases (2006), Imperial College Press, London 337-402
11. Lewis D.A., Hashimoto T., and Volk D.W. Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci 6 (2005) 312-324
12. Lieberman J.A., Perkins D., Belger A., Chakos M., Jarskog F., Boteva K., et al. The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches. Biol Psychiat 50 (2001) 884-897
13. Liebsch G., Montkowski A., Holboer F., and Landgraf R. Behavioural profiles of two rat lines selectively bred for high or low anxiety-related behaviour. Behav Brain Res 49 (1998) 301-310
14. Lipska B.K., and Weinberger D.R. To model a psychiatric disorder in animals: schizophrenia as a reality test. Neuropsychopharmacology 23 (2000) 223-239
15. Racine R.J., Steingart M., and McIntyre D.C. Development of kindling-prone and kindling-resistent rats: selective breeding and electrophysiological studies. Epilep Res 35 (1999) 183-195
16. Swerdlow N.R., and Geyer M.A. Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia. Pharmacol Biochem Behav 44 (1993) 741-744
17. Swerdlow N.R., and Geyer M.A. Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophr Bull 24 (1998) 285-301
18. Swerdlow N.R., Bakshi V., Waikar M., Taaid N., and Geyer M.A. Seroquel, clozapine and chlorpromazine restore sensorimotor gating in ketamine-treated rats. Psychopharmacology 140 (1998) 75-80
19. Swerdlow N.R., Braff D.L., and Geyer M.A. Animal models of deficient sensorimotor gating: what we know, what we think to know, and what we hope to know soon. Behav Pharmacol 11 (2000) 185-204
20. Swerdlow N.R., Geyer M.A., and Braff D.L. Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology 156 (2001) 194-215
21. Swerdlow N.R., Shoemaker J.M., Crain S., Goins J., Onozuka K., and Auerbach P.P. Sensitivity to drug effects on prepulse inhibition in inbred and outbred rat strains. Pharmacol Biochem Behav 77 (2004) 291-302